ArticleResearch in pharmaceutical sciences2025
Repurposing FDA-approved drugs to find a novel inhibitor of alpha-ketoglutarate-dependent dioxygenase FTO to treat esophageal cancer.
Zeinab Mohammadi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.